Details for 2018171672

Up to date per 01.04.2026

Actions

Title / Product Name

DURCH SUBSTITUIERTES BETA-CYCLODEXTRIN STABILISIERTE INTRAVENÖSE POSACONAZOLLÖSUNGSFORMULIERUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018171672

EP Publication Number

3391890

E-Number

1423096

Language

PCT Number

Publication Date

24.10.2018 A

25.08.2021 B1

Registration Date

25.08.2021

AT Publication Date

15.09.2021

Application Date

24.06.2011

Registration Number

Priorities

29.06.2010

359701 P

IPC

A61K 31/715 20060101AFI20210222BHEP

Maximum Duration of Protection

24.06.2031

Owner

Merck Sharp & Dohme LLC126 East Lincoln Avenue Rahway, New Jersey 07065US

Representative

Patentanwalt Mikšovsky KGBisamberger Straße 192100 KorneuburgAT

Inventor

Heimbecher, Susan, K.556 Morris Avenue Summit, New Jersey 07901-1330US

Monteith, David556 Morris Avenue Summit, New Jersey 07901-1330US

Information about Fees